Memorial Sloan Kettering Partners Lumonus To Advance AI Radiation Planning

Memorial Sloan Kettering Cancer Center is collaborating with Lumonus to bring a clinically validated optimization system into broader use, aiming to improve how radiation therapy plans are created and delivered.

The New York–based cancer center will license and co-develop its ECHO optimization engine within Lumonus’ platform, according to a press release from Lumonus. The effort focuses on automating one of the most complex parts of radiation oncology: generating treatment plans that balance competing clinical constraints for each patient.

ECHO was developed at Memorial Sloan Kettering Cancer Center over nearly a decade and uses constraint-based mathematical optimization to compute radiation treatment plans. The system is designed to determine the best possible configuration based on clinical goals, rather than relying on manual iteration.

“Our goal in developing ECHO has always been to improve the quality, consistency, and efficiency of radiation therapy treatment planning,” Masoud Zarepisheh, Associate Attending and lead developer of ECHO at MSK, said in the release.